CPI203
CPI 203 (TEN 010, JQ-2, RG-6146) is a primary amide analog of (+) -JQ1and a BET bromodomain inhibitor that shows cytotoxicity against MCL cell lines with GI50 of 0.1-0.3 uM; synergizes the antitumor activity of lenalidomide in bortezomib-resistant mantle cell lymphoma; also enhances the antiproliferative effects of rapamycin on human neuroendocrine tumors, overcomes resistance to ABT-199 (Venetoclax) by downregulation of BFL-1/A1 in in vitro and in vivo models of MYC+/BCL2+ double hit lymphoma.
Product Specifications
CAS Number
1446144-04-2
Product Name Alternative
TEN 010 | JQ-2 | RG-6146
Purity
>98% (HPLC)
Solubility
DMSO: 72 mg/mL (180 mM) ; Ethanol: 5 mg/mL (12.5 mM) ; Water: <1 mg/mL (< 1 mg/ml refers to the product slightly soluble or insoluble)
Smiles
O=C (N) C[C@H]1C2=NN=C (C) N2C3=C (C (C) =C (C) S3) C (C4=CC=C (Cl) C=C4) =N1
Molecular Formula
C19H18ClN5OS
Molecular Weight
399.897
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
(6S) -4- (4-chlorophenyl) -2,3,9-trimethyl-6H-thieno[3,2-f][1,2,4]triazolo[4,3-a][1,4]diazepine-6-acetamide
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog